Browse By Region
Browse By Category
Recent News
By Category: Biotechnology
Protest Filed Against BARDA Over Smallpox Antiviral Biodefense Contract
Siga, a pharmaceutical company that develops medicines to fight the effects of potential bioterrorism attacks, announced Friday afternoon that it had won a contract to deliver its smallpox antiviral medicine to the government's stockpile of emergency …
- May 16, 2011
- | Filed under North America, Biotechnology, and Countermeasures
DNA2.0 Opens Gene Marketplace
PR WEB — (Boston, MA) – DNA2.0 today announced that it will offer third-party genetic constructs through the company’s groundbreaking gene assembly and design application, Gene Designer. The Rhamex™ protein expression systems from Xbrane Bioscience will be the first commercial constructs that users will be able to access and order directly through Gene Designer. In Read More »
- May 12, 2011
- | Filed under North America and Biotechnology
FBI: Suspicious letters mailed to DC schools
ASSOCIATED PRESS — More than 20 letters that contained a white, powdery substance delivered to District of Columbia schools on Thursday are similar to those mailed to schools elsewhere in the U.S. over the last several weeks, the FBI said. Preliminary testing by hazardous materials crews found the powder in the letters received in the Read More »
- May 6, 2011
- | Filed under North America, Biotechnology, and Bioterrorism
San Francisco Bill Could Harm Biodefense Industry: Experts
A bill introduced by the San Francisco Board of Supervisors that would mandate the certification of privately owned disease agent sensors would also hobble market incentives for the development of new biological defense technologies, two policy experts said in a commentary last week (see GSN, March 25). Authorities are “right to be concerned” about erroneous Read More »
- April 4, 2011
- | Filed under North America and Biotechnology
Pall Introduces First Sterile Disconnection Device For Use With Bioprocessing Containers During The Manufacture Of Biologicals
Pall Corporation (NYSE: PLL) is launching an innovative solution for convenient and secure sterile separation of flexible tubing assemblies. The single-use Pall Kleenpak Sterile Disconnector facilitates secure fluid transfer, preserves product integrity, improves operator safety, and reduces product waste at all process stages of biopharmaceutical manufacturing…
- March 31, 2011
- | Filed under North America and Biotechnology